Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to Note
06:51pm, Tuesday, 16'th Jul 2024
In the most recent trading session, Novo Nordisk (NVO) closed at $140.87, indicating a -0.37% shift from the previous trading day.
3 Hot Growth Stocks That Will Make You Forget About AMD
06:44pm, Tuesday, 16'th Jul 2024
Advanced Micro Devices (NASDAQ: AMD ) stock has been heating up for July. The top rival of Nvidia (NASDAQ: NVDA ) recently announced its intent to acquire Silo AI in an all-cash deal worth around $665
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
10:07am, Tuesday, 16'th Jul 2024
Novo Nordisk (NVO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
4 Large Drug Stocks to Watch as Innovation, M&A Pick Up
09:57am, Tuesday, 16'th Jul 2024
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Pfizer (PFE) are worth retaining i
Novo Nordisk investor backs $100m Alzheimer's funding round
07:38am, Tuesday, 16'th Jul 2024
Novo Holdings, the main shareholder of Novo Nordisk (NYSE:NVO), has led a $100 million Series C funding round for Swiss company Asceneuron, which is developing a next-generation treatment for Alzheim
7 Top-Quality Stocks to Buy Now: July 2024
01:00pm, Monday, 15'th Jul 2024
Investors should look for top-quality stocks for the remainder of the year. With plenty of uncertainties, a nearing presidential election, geopolitical issues, and a lack of a clear economic trajector
Novo Nordisk (NVO) GLP-1 Drug Regarded Safe for Brain by Oxford
12:46pm, Monday, 15'th Jul 2024
Oxford study demonstrates that Novo Nordisk's (NVO) semaglutide is not associated with a risk of adverse neuropsychiatric outcomes compared with other antidiabetic medications over one year.
Here's 80 Billion More Reasons to Buy Novo Nordisk Stock
05:52pm, Saturday, 13'th Jul 2024
Novo Nordisk is already developing its next set of weight loss therapies. At least one market research firm is incredibly optimistic about its prospects.
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market
04:08pm, Friday, 12'th Jul 2024
Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting insulins in the country, two sources familiar
Ozempic linked with lower dementia risk, nicotine use, British study finds
01:40pm, Friday, 12'th Jul 2024
Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University.
PFE or NVO: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 12'th Jul 2024
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks offers value investors a bett
Novo Nordisk Gains as Ozempic Found To Lower Dementia Rates
11:55am, Friday, 12'th Jul 2024
American depositary receipts (ADRs) of Novo Nordisk (NVO) rose in intraday trading Friday after the release of an Oxford study that showed the Danish company's Ozempic diabetes drug was linked to lowe
Study finds Novo Nordisk's Ozempic may reduce dementia
07:33am, Friday, 12'th Jul 2024
The study looked at semaglutide, the scientific name for Novo Nordisk's NVO, -2.07% NOVO.B, +0.52% Ozempic, with the intent of looking at whether it caused neurological problems. Instead, it found a 4
3 Global Stocks Worth Buying as America Stumbles
07:07am, Friday, 12'th Jul 2024
MoneyWeek columnist Bill Bonner wrote in the June 28 edition of the U.K. financial publication that the two men running for president of the United States are perfect candidates for a nation in declin
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
06:15am, Friday, 12'th Jul 2024
Undervalued pharma stocks can make good investments, whether during times of a booming economy or a faltering one. That is because people will still need medications and healthcare services regardless
